山东省药用玻璃股份有限公司 关于使用闲置募集资金购买理财产品的进展公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ●委托理财受托方:中国工商银行股份有限公司 ●委托理财金额：人民币 13,000.00 万元 ●委托理财产品名称：挂钩汇率区间累计型法人人民币结构性存 款产品-专户型 2025 年第 150 期 B 款 证券代码：600529 证券简称：山东药玻 公告编号：2025-013 ●委托理财产品期限：21 天 ●履行的审议程序：公司于 2024 年 4 月 20 日召开了第十届董事 会第十二次会议和第十届监事会第十次会议，并于 2024 年 5 月 16 日 召开了 2023 年年度股东大会，审议通过了《关于使用闲置募集资金 购买理财产品的议案》，同意公司使用总额度不超过人民币 10 亿元的 暂时闲置募集资金进行购买安全性高、流动性好、期限不超过 12 个 月（含）的保本型理财产品（包括但不限于协定性存款、结构性存款、 定期存款、通知存款、大额存单等），并在上述额度内滚动使用，募 集资金理财使用 ...

Core Viewpoint - The China Securities Index for Healthcare Equipment and Services has shown a recent increase, but it has experienced declines over the past month, three months, and year-to-date [1]. Group 1: Index Performance - The CSI Healthcare Equipment and Services Index rose by 1.17% to 13,221.28 points with a trading volume of 10.971 billion [1]. - Over the past month, the index has decreased by 9.68%, by 0.46% over the last three months, and by 4.54% year-to-date [1]. Group 2: Index Composition - The index is composed of listed companies in the healthcare sector, reflecting the overall performance of these securities [1]. - The top ten weighted companies in the index include Mindray Medical (9.26%), Aier Eye Hospital (8.31%), and United Imaging Healthcare (7.36%) [1]. - The index's holdings are primarily from the Shenzhen Stock Exchange (60.12%) and the Shanghai Stock Exchange (39.88%) [1]. Group 3: Fund Tracking - Public funds tracking the healthcare index include several funds such as Southern CSI Healthcare Equipment and Services Link A, Tianhong CSI Healthcare Equipment and Services ETF, and others [2].

Investment Rating - The report indicates a positive outlook for the real estate sector, emphasizing its role in boosting domestic demand and stabilizing the market [1][12]. Core Insights - The real estate market is transitioning back to its residential function, with significant declines in new home sales and construction activities projected for 2022-2024 [1][12]. - The implementation of new policies on May 17, 2024, aims to support the real estate market, including adjustments to loan rates and down payment requirements [1][12]. - Infrastructure projects are also highlighted as key drivers of domestic demand, particularly in regions like Xinjiang and Guangxi, with significant investments underway [2][13]. - The "Belt and Road" initiative remains a focal point for international expansion, with ongoing collaborations between China and Vietnam to enhance infrastructure connectivity [2][13]. Summary by Sections Weekly Discussion - The report discusses the importance of real estate in stimulating domestic demand, noting a shift towards residential needs and a significant drop in key market indicators [1][12]. - It highlights the recent government meetings aimed at stabilizing the real estate market and the potential impact of new policies on housing loans [1][12]. Cyclical Linkage - Cement prices have shown a year-on-year increase, with the national average price at 395 RMB/t, while glass prices have also seen slight increases [3][14]. - The report notes a stable demand for aluminum and steel, with expectations for continued high supply levels [3][14]. National Subsidy Tracking - Various regions have successfully implemented consumer subsidies, such as Shanghai's 1.8 billion RMB for home appliance upgrades, significantly boosting sales [4][15]. - The report suggests focusing on companies related to subsidized products in the construction materials sector [4][15]. Important Developments - The report mentions the strengthening of the strategic partnership between China and Vietnam, along with significant stock purchases by major shareholders in various companies [5][16]. - It emphasizes the government's commitment to stabilizing the stock market and supporting the real estate sector [5][16]. Market Performance (April 14-18) - The construction materials index experienced a slight decline, with specific segments like refractory materials and pipes performing better than others [17]. Construction Material Price Changes - Cement prices have slightly decreased in certain regions, while glass prices have shown minor increases, indicating a mixed market response [29][39]. - The report provides detailed statistics on the pricing trends and inventory levels for various construction materials [29][39].

Group 1 - The core point of the news is the performance and holdings of the Jiao Yin State-Owned Enterprise Reform Flexible Allocation Mixed A Fund, which has a latest net value of 1.7329 yuan, showing a growth of 0.55% [1] - The fund's recent performance includes a -1.21% return over the past month, a 5.20% return over the past six months, and a 1.68% return year-to-date, with respective rankings of 609 out of 2325, 607 out of 2283, and 659 out of 2308 [1] - The fund's top ten stock holdings account for a total of 50.00%, with significant positions in companies such as SF Holding (9.81%), China Chemical (6.05%), and Kingsoft Office (5.89%) [1] Group 2 - The Jiao Yin State-Owned Enterprise Reform Flexible Allocation Mixed A Fund was established on June 10, 2015, and as of December 31, 2024, it has a total scale of 2.2 billion yuan [1] - The fund manager, Shen Nan, has been in the role since the fund's inception and has a background in finance, having worked as a senior analyst and assistant fund manager prior to his current position [2]

公司于 2024 年 4 月 20 日召开了第十届董事会第十二次会议和第 十届监事会第十次会议，并于 2024 年 5 月 16 日召开了 2023 年年度 股东大会，审议通过了《关于使用闲置募集资金购买理财产品的议案》， 同意公司使用总额度不超过人民币 10 亿元的暂时闲置募集资金进行 购买安全性高、流动性好、期限不超过 12 个月（含）的保本型理财 产品（包括但不限于协定性存款、结构性存款、定期存款、通知存款、 大额存单等），并在上述额度内滚动使用，募集资金理财使用额度及 授权的有效期为自议案经公司 2023 年年度股东大会审议通过之日起 12 个月内有效。具 体 内 容 详 见 公司 在 上 海 证 券 交易 所 网 站 （www.sse.com.cn）披露的《山东省药用玻璃股份有限公司关于使用 闲置募集资金购买理财产品的公告》（公告编号：2024-026）。 一、使用暂时闲置募集资金购买理财产品到期赎回的情况 公司于 2024 年 12 月 30 日以闲置募集资金人民币 13,000.00 万 元购买了中国工商银行股份有限公司挂钩汇率区间累计型法人人民 币结构性存款产品-专户型 2024 年第 466 ...

Core Viewpoint - The China Securities Index for Healthcare Equipment and Services has shown a mixed performance, with a recent increase but a decline over the past month and year-to-date [1] Group 1: Index Performance - The CSI Healthcare Equipment and Services Index rose by 0.32% to 13,285.51 points, with a trading volume of 13.924 billion yuan [1] - Over the past month, the index has decreased by 8.06%, while it has increased by 4.05% over the last three months and has declined by 3.25% year-to-date [1] Group 2: Index Composition - The index is composed of listed companies in the healthcare sector, reflecting the overall performance of these securities [1] - The top ten weighted companies in the index include Mindray Medical (9.16%), Aier Eye Hospital (8.31%), and United Imaging Healthcare (7.43%) [1] - The index is primarily composed of companies listed on the Shenzhen Stock Exchange (60.27%) and the Shanghai Stock Exchange (39.73%) [1] Group 3: Sample Adjustment and Fund Tracking - The index samples are adjusted biannually, with adjustments occurring on the second Friday of June and December [2] - Public funds tracking the healthcare index include several funds from Southern Asset Management and Tianhong Asset Management [2]

Core Points - The Shanghai Composite Index opened lower and fluctuated, while the CSI All Index for Healthcare Equipment and Services decreased by 0.16%, closing at 14,029.54 points with a trading volume of 15.519 billion yuan [1] - Over the past month, the CSI All Index for Healthcare Equipment and Services has increased by 0.23%, and over the past three months, it has risen by 2.65%, with a year-to-date increase of 2.65% [1] - The index reflects the overall performance of listed companies in the healthcare sector, selected from the CSI All Index, with a base date of December 31, 2004, set at 1,000.0 points [1] Index Composition - The top ten weighted companies in the CSI All Index for Healthcare Equipment and Services are: Mindray Medical (9.28%), Aier Eye Hospital (8.07%), United Imaging (6.7%), Aimeike (3.56%), Huatai Medical (3.16%), New Industry (3.09%), Yuyue Medical (2.83%), Meinian Onehealth (2.33%), Jiuan Medical (2.16%), and Shandong Pharmaceutical Glass (2.05%) [1] - The market share of the index's holdings is 61.07% from the Shenzhen Stock Exchange and 38.93% from the Shanghai Stock Exchange [1] - The index's holdings are entirely composed of the pharmaceutical and healthcare sector, with a 100.00% allocation [1] Index Adjustment and Fund Tracking - The index samples are adjusted semi-annually, with adjustments occurring on the next trading day after the second Friday of June and December each year [2] - Weight factors are adjusted in accordance with the sample changes, typically remaining fixed until the next scheduled adjustment, with provisions for temporary adjustments in special circumstances [2] - Public funds tracking the healthcare index include various funds from Southern Fund, Tianhong Fund, and others, specifically designed to follow the CSI All Index for Healthcare Equipment and Services [2]

证券代码：600529 证券简称：山东药玻 编号：2025-011 山东省药用玻璃股份有限公司 关于控股股东部分股份质押的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实、准确和完整承担个别及连带责任。 重要内容提示: ●山东鲁中投资有限责任公司（以下简称"鲁中投资"）持有山东省 药用玻璃股份有限公司（以下简称"本公司"、"公司"）股份数量 129,380,980 股（无限售流通股），占公司股份总数的 19.50%，为本公司 控股股东。 ●截至公告披露日，鲁中投资累计质押 58,180,000 股股份，占本公司 总股本的 8.77%,占其所持本公司股份总数的 44.97%。 2025年3月28日公司收到鲁中投资转来的《关于控股股东山东鲁中投资 有限责任公司股权质押的基本情况》，获悉其所持有本公司的部分股份办 理了质押，具体事项如下： 2、本次被质押股份不存在被用作重大资产重组业绩补偿等事项的担保 或用于其他保障用途。 股东名 称 是否为 控股股 东 本次质押股 数 是否 为限 售股 是否 补充 质押 质押起始日 质押到 期日 质权人 占其 ...

山东药玻: 山东省药用玻璃股份有限公司关于控股 股东部分股份解除质押的公告 证券代码：600529 证券简称：山东药玻 编号：2025-010 山东省药用玻璃股份有限公司 关于控股股东部分股份解除质押的公告 鲁中投资有限责任公司（以下简称"鲁中投资"）持有公司股份总数为 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述 或者重 大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: ，占公司总股本比例为 19.50%。 占其持股数量的比例为 41.10%， 公司于 2025 年 3 月 24 日收到鲁中投资转来的关于公司控股股东山东 鲁中投资有限责任公司股权解除质押的基本情况，获悉其将所持有的本公 司部分股份办理了解除质押。本次解除质押股份为 2022 年 3 月 25 日质押 给中泰证券股份有限公司的 5,000,000 股； 具体事项如下： | 股东名称 山东鲁中投资有限责任公司 | | | | --- | --- | --- | | 本次解质股份（股） | | 5,000,000 | | 占其所持股份比例 | | 3.86% | | 占公司总股本比例 | | 0. ...

山东省药用玻璃股份有限公司 关于控股股东部分股份解除质押的公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述 或者重 大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: 1、山东省药用玻璃股份有限公司（以下简称"公司"）控股股东山东 鲁中投资有限责任公司（以下简称"鲁中投资"）持有公司股份总数为 129,380,980 股（无限售流通股），占公司总股本比例为 19.50%。 2、本次解除质押后，鲁中投资持有公司股份累计质押数量为 53,180,000 股，占其持股数量的比例为 41.10%，占公司总股本比例为 8.01%。 公司于 2025 年 3 月 24 日收到鲁中投资转来的关于公司控股股东山东 鲁中投资有限责任公司股权解除质押的基本情况，获悉其将所持有的本公 司部分股份办理了解除质押。本次解除质押股份为 2022 年 3 月 25 日质押 给中泰证券股份有限公司的 5,000,000 股； 证券代码：600529 证券简称：山东药玻 编号：2025-010 具体事项如下： | 股东名称 | 山东鲁中投资有限责任公司 | | | | | --- | --- ...